Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jay S Cooper

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Head & Neck|September 15, 2005
Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501)Jacques Bernier, Jay S Cooper, T F Pajak, et al.
International Journal of Radiation Oncology, Biology, Physics|January 9, 2007
An evaluation of the variability of tumor-shape definition derived by experienced observers from CT images of supraglottic carcinomas (ACRIN protocol 6658)Jay S Cooper, Suresh K Mukherji, Alicia Y Toledano, et al.
The Oncologist|January 14, 2012
Immunogenicity of an inactivated monovalent 2009 influenza A (H1N1) vaccine in patients who have cancerYiqing Xu, Nanda Methuku, Praveena Coimbatore, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 2, 2011
Glioma-associated oncogene family zinc finger 1 expression and metastasis in patients with head and neck squamous cell carcinoma treated with radiation therapy (RTOG 9003)Christine H Chung, James J Dignam, M Elizabeth Hammond, et al.
Head & Neck|May 1, 2016
ACR Appropriateness criteria® for nasopharyngeal carcinomaNabil F Saba, Joseph K Salama, Jonathan J Beitler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 28, 2012
Long-term results of RTOG 91-11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancerArlene A Forastiere, Qiang Zhang, Randal S Weber, et al.
Head & Neck|June 23, 2016
ACR Appropriateness Criteria(®) Locoregional therapy for resectable oropharyngeal squamous cell carcinomasJonathan J Beitler, Harry Quon, Christopher U Jones, et al.
Head & Neck|December 30, 2016
ACR appropriateness criteria<sup>®</sup> nasal cavity and paranasal sinus cancersFarzan Siddiqui, Richard V Smith, Sue S Yom, et al.
International Journal of Radiation Oncology, Biology, Physics|April 8, 2022
Nodal Metastasis Count and Oncologic Outcomes in Head and Neck Cancer: A Secondary Analysis of NRG/RTOG 9501, NRG/RTOG 0234, and EORTC 22931Diana J Lu, Michael Luu, Christopher Gay, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 4, 2003
CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC,RTOG consensus guidelinesVincent Grégoire, Peter Levendag, Kian K Ang, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Head & Neck|September 15, 2005
Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501)Jacques Bernier, Jay S Cooper, T F Pajak, et al.
International Journal of Radiation Oncology, Biology, Physics|January 9, 2007
An evaluation of the variability of tumor-shape definition derived by experienced observers from CT images of supraglottic carcinomas (ACRIN protocol 6658)Jay S Cooper, Suresh K Mukherji, Alicia Y Toledano, et al.
The Oncologist|January 14, 2012
Immunogenicity of an inactivated monovalent 2009 influenza A (H1N1) vaccine in patients who have cancerYiqing Xu, Nanda Methuku, Praveena Coimbatore, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 2, 2011
Glioma-associated oncogene family zinc finger 1 expression and metastasis in patients with head and neck squamous cell carcinoma treated with radiation therapy (RTOG 9003)Christine H Chung, James J Dignam, M Elizabeth Hammond, et al.
Head & Neck|May 1, 2016
ACR Appropriateness criteria® for nasopharyngeal carcinomaNabil F Saba, Joseph K Salama, Jonathan J Beitler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 28, 2012
Long-term results of RTOG 91-11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancerArlene A Forastiere, Qiang Zhang, Randal S Weber, et al.
Head & Neck|June 23, 2016
ACR Appropriateness Criteria(®) Locoregional therapy for resectable oropharyngeal squamous cell carcinomasJonathan J Beitler, Harry Quon, Christopher U Jones, et al.
Head & Neck|December 30, 2016
ACR appropriateness criteria<sup>®</sup> nasal cavity and paranasal sinus cancersFarzan Siddiqui, Richard V Smith, Sue S Yom, et al.
International Journal of Radiation Oncology, Biology, Physics|April 8, 2022
Nodal Metastasis Count and Oncologic Outcomes in Head and Neck Cancer: A Secondary Analysis of NRG/RTOG 9501, NRG/RTOG 0234, and EORTC 22931Diana J Lu, Michael Luu, Christopher Gay, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 4, 2003
CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC,RTOG consensus guidelinesVincent Grégoire, Peter Levendag, Kian K Ang, et al.
Pageof 4